Future Of US FDA’s Diversity Action Plan Guidance ‘Up In The Air’ As Statutory Deadline Looms

 
• By Sue Sutter
  
Questions in a jar
The timing and content of an FDA diversity action plan final guidance are uncertain. (Shutterstock)

More from Diversity & Inclusion

More from Conferences